Ecor1-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "ORIC",
  "JAZZ",
  "MDGL",
  "APLS",
  "GLPG",
  "DNA",
  "PRME",
  "TCRX",
  "ANAB",
  "BCYC",
  "TNGX",
  "RLAY",
  "TECX",
  "REPL",
  "KROS",
  "PRTA",
  "NGNE",
  "ALGS",
  "JANX",
  "ATRA",
  null,
  "WHWK",
  null,
  null,
  "ZYME",
  "UPB",
  "RNA",
  "MBX",
  "SLDB",
  "QURE",
  "ADAP",
  "SRPT",
  "IMNM",
  "KLRS",
  "KURA",
  "ETON",
  "VERV",
  "VYGR",
  "XNCR",
  "BEAM",
  "CRNX",
  "CRSP",
  "DAWN"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 44
Total Value: 1618567932
Accession Number: 0000935836-25-000338
Form Type: 13F-HR
CIK: ecor1-capital
Manager Name: Ecor1-Capital

Data Enrichment

93% identified

41 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

44 positions • $1.6B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 3

Sort by:

Beam Therapeutics Inc.

BEAM|07373V105

Shares:526.7K

Value:$10.3M

% of Portfolio:0.6% ($10.3M/$1.6B)

MBX Biosciences, Inc.

MBX|55287L101

Shares:1.3M

Value:$9.3M

% of Portfolio:0.6% ($9.3M/$1.6B)

Ginkgo Bioworks Holdings, Inc.

DNA|37611X209

Shares:1.5M

Value:$8.3M

% of Portfolio:0.5% ($8.3M/$1.6B)

Replimune Group, Inc.

REPL|76029N106

Shares:850.3K

Value:$8.3M

% of Portfolio:0.5% ($8.3M/$1.6B)

BICYCLE THERAPEUTICS PLC

BCYC|088786108

Shares:910.0K

Value:$7.7M

% of Portfolio:0.5% ($7.7M/$1.6B)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:862.1K

Value:$6.8M

% of Portfolio:0.4% ($6.8M/$1.6B)

Verve Therapeutics, Inc.

VERV|92539P101

Shares:1.3M

Value:$5.7M

% of Portfolio:0.4% ($5.7M/$1.6B)

Adaptimmune Therapeutics PLC

ADAP|00653A107

Shares:27.4M

Value:$5.4M

% of Portfolio:0.3% ($5.4M/$1.6B)

GALAPAGOS NV

GLPG|36315X101

Shares:155.0K

Value:$3.9M

% of Portfolio:0.2% ($3.9M/$1.6B)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

Shares:2.1M

Value:$3.7M

% of Portfolio:0.2% ($3.7M/$1.6B)

Atara Biotherapeutics, Inc.

ATRA|046513206

Shares:573.2K

Value:$3.4M

% of Portfolio:0.2% ($3.4M/$1.6B)

Solid Biosciences Inc.

SLDB|83422E204

Shares:744.5K

Value:$2.8M

% of Portfolio:0.2% ($2.8M/$1.6B)

Keros Therapeutics, Inc.

KROS|492327101

Shares:187.5K

Value:$1.9M

% of Portfolio:0.1% ($1.9M/$1.6B)

67080N119

Shares:963.3K

Value:$1.7M

% of Portfolio:0.1% ($1.7M/$1.6B)

Relay Therapeutics, Inc.

RLAY|75943R102

Shares:641.4K

Value:$1.7M

% of Portfolio:0.1% ($1.7M/$1.6B)

Kalaris Therapeutics, Inc.

KLRS|482929106

Shares:201.7K

Value:$1.6M

% of Portfolio:0.1% ($1.6M/$1.6B)

uniQure N.V.

QURE|N90064101

Shares:135.0K

Value:$1.4M

% of Portfolio:0.1% ($1.4M/$1.6B)

Prime Medicine, Inc.

PRME|74168J101

Shares:700.0K

Value:$1.4M

% of Portfolio:0.1% ($1.4M/$1.6B)

59267L107

Shares:50.0K

Value:$1.4M

% of Portfolio:0.1% ($1.4M/$1.6B)

TScan Therapeutics, Inc.

TCRX|89854M101

Shares:662.8K

Value:$914.7K

% of Portfolio:0.1% ($914.7K/$1.6B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Beam Therapeutics Inc.(BEAMcusip07373V105)	526.7K	QoQ NEW(+526.7K) YoY NEW(+526.7K)	All Managers (Combined)	$10.3M	0.6% ($10.3M/$1.6B)	QoQ NEW(+$10.3M) YoY NEW(+$10.3M)
MBX Biosciences, Inc.(MBXcusip55287L101)	1.3M	QoQ 0.00% (-0) YoY NEW(+1.3M)	All Managers (Combined)	$9.3M	0.6% ($9.3M/$1.6B)	QoQ -59.95% (-$13.9M) YoY NEW(+$9.3M)
Ginkgo Bioworks Holdings, Inc.(DNAcusip37611X209)	1.5M	QoQ -16.11% (-281.0K) YoY NEW(+1.5M)	All Managers (Combined)	$8.3M	0.5% ($8.3M/$1.6B)	QoQ -51.31% (-$8.8M) YoY NEW(+$8.3M)
Replimune Group, Inc.(REPLcusip76029N106)	850.3K	QoQ 0.00% (-0) YoY NEW(+850.3K)	All Managers (Combined)	$8.3M	0.5% ($8.3M/$1.6B)	QoQ -19.48% (-$2.0M) YoY NEW(+$8.3M)
BICYCLE THERAPEUTICS PLC(BCYCcusip088786108)	910.0K	QoQ 0.00% (-0) YoY NEW(+910.0K)	All Managers (Combined)	$7.7M	0.5% ($7.7M/$1.6B)	QoQ -39.35% (-$5.0M) YoY NEW(+$7.7M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	862.1K	QoQ 0.00% (-0) YoY NEW(+862.1K)	All Managers (Combined)	$6.8M	0.4% ($6.8M/$1.6B)	QoQ -37.41% (-$4.1M) YoY NEW(+$6.8M)
Verve Therapeutics, Inc.(VERVcusip92539P101)	1.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.7M	0.4% ($5.7M/$1.6B)	QoQ -18.97% (-$1.3M) YoY -65.58% (-$10.9M)
Adaptimmune Therapeutics PLC(ADAPcusip00653A107)	27.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.4M	0.3% ($5.4M/$1.6B)	QoQ -63.43% (-$9.4M) YoY -87.53% (-$37.9M)
GALAPAGOS NV(GLPGcusip36315X101)	155.0K	QoQ 0.00% (-0) YoY -97.30% (-5.6M)	All Managers (Combined)	$3.9M	0.2% ($3.9M/$1.6B)	QoQ -8.65% (-$368.9K) YoY -97.89% (-$181.5M)
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	2.1M	QoQ +503.03% (+1.7M) YoY NEW(+2.1M)	All Managers (Combined)	$3.7M	0.2% ($3.7M/$1.6B)	QoQ +240.22% (+$2.6M) YoY NEW(+$3.7M)
Atara Biotherapeutics, Inc.(ATRAcusip046513206)	573.2K	QoQ +7.71% (-41.0K) YoY NEW(+573.2K)	All Managers (Combined)	$3.4M	0.2% ($3.4M/$1.6B)	QoQ -51.92% (-$3.7M) YoY NEW(+$3.4M)
Solid Biosciences Inc.(SLDBcusip83422E204)	744.5K	QoQ NEW(+744.5K) YoY NEW(+744.5K)	All Managers (Combined)	$2.8M	0.2% ($2.8M/$1.6B)	QoQ NEW(+$2.8M) YoY NEW(+$2.8M)
Keros Therapeutics, Inc.(KROScusip492327101)	187.5K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.9M	0.1% ($1.9M/$1.6B)	QoQ -35.62% (-$1.1M) YoY -84.60% (-$10.5M)
(cusip67080N119)✕	963.3K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.7M	0.1% ($1.7M/$1.6B)	QoQ -33.83% (-$867.0K) YoY -51.64% (-$1.8M)
Relay Therapeutics, Inc.(RLAYcusip75943R102)	641.4K	QoQ 0.00% (-0) YoY NEW(+641.4K)	All Managers (Combined)	$1.7M	0.1% ($1.7M/$1.6B)	QoQ -36.40% (-$962.1K) YoY NEW(+$1.7M)
Kalaris Therapeutics, Inc.(KLRScusip482929106)	201.7K	QoQ NEW(+201.7K) YoY NEW(+201.7K)	All Managers (Combined)	$1.6M	0.1% ($1.6M/$1.6B)	QoQ NEW(+$1.6M) YoY NEW(+$1.6M)
uniQure N.V.(QUREcusipN90064101)	135.0K	QoQ -64.93% (-250.0K) YoY NEW(+135.0K)	All Managers (Combined)	$1.4M	0.1% ($1.4M/$1.6B)	QoQ -78.95% (-$5.4M) YoY NEW(+$1.4M)
Prime Medicine, Inc.(PRMEcusip74168J101)	700.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.4M	0.1% ($1.4M/$1.6B)	QoQ -31.84% (-$651.0K) YoY -71.57% (-$3.5M)
(cusip59267L107)✕	50.0K	QoQ NEW(+50.0K) YoY NEW(+50.0K)	All Managers (Combined)	$1.4M	0.1% ($1.4M/$1.6B)	QoQ NEW(+$1.4M) YoY NEW(+$1.4M)
TScan Therapeutics, Inc.(TCRXcusip89854M101)	662.8K	QoQ -86.74% (-4.3M) YoY -86.74% (-4.3M)	All Managers (Combined)	$914.7K	0.1% ($914.7K/$1.6B)	QoQ -93.98% (-$14.3M) YoY -97.69% (-$38.8M)